Table 1.
Characteristics and demographic data.
Fig 1.
Spectrum of genetic alterations among patients with lung adenocarcinoma.
Table 2.
Characteristics of genetic alterations assessed in the present study.
Fig 2.
Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung adenocarcinoma (complex mutations are counted as separated mutation types here).
Table 3.
Univariate analysis of genetic alterations and clinical characteristics.
Table 4.
Univariate analysis of objective response rate and disease control rate in patients harboring EGFR mutations (n = 352).